Rubicon Research Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON RESEARCH
RUBICON RESEARCH has seventy-five approved drugs.
Summary for Rubicon Research
| US Patents: | 0 |
| Tradenames: | 61 |
| Ingredients: | 60 |
| NDAs: | 75 |
Drugs and US Patents for Rubicon Research
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon Research | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078625-001 | Jan 27, 2009 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rubicon Research | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 209779-001 | May 3, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rubicon Research | METOLAZONE | metolazone | TABLET;ORAL | 215184-001 | Aug 20, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
